Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rudofsky, G.
Right arrow Articles by Bierhaus, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rudofsky, G., Jr
Right arrow Articles by Bierhaus, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 27:179-183, 2004
© 2004 by the American Diabetes Association, Inc.


Pathophysiology/Complications
Original Article

Asp299Gly and Thr399Ile Genotypes of the TLR4 Gene Are Associated With a Reduced Prevalence of Diabetic Neuropathy in Patients With Type 2 Diabetes

Gottfried Rudofsky, Jr, MD1, Peter Reismann1, Steffen Witte, BOS2, Per M. Humpert, MD1, Berend Isermann, MD1, Triantafyllos Chavakis, MD1, Jörg Tafel, MD1, Valery V. Nosikov, PHD3, Andreas Hamann, MD1, Peter Nawroth, MD1 and Angelika Bierhaus, PHD1

1 Department Medicine I, University of Heidelberg, Heidelberg, Germany
2 Department of Medical Biometry, University of Heidelberg, Heidelberg, Germany
3 Department of Molecular Diagnostics and Genomic Fingerprinting, National Research Centre "GosNII Genetika," Moscow, Russia

Address correspondence and reprint requests to Angelika Bierhaus, PhD, Medizinische Klinik I der Universität Heidelberg, Otto-Meyerhof-Zentrum, Im Neuenheimer Feld 350, 69120 Heidelberg, Germany. E-mail: angelika_bierhaus{at}med.uni-heidelberg.de

OBJECTIVE—To establish whether single nucleotide polymorphisms (Asp299Gly and Thr399Ile) of the toll-like receptor 4 have an association with late diabetic complications.

RESEARCH DESIGN AND METHODS—The study was conducted in 246 type 1 and 530 type 2 diabetic patients. The alleles of both polymorphisms were detected using PCR and subsequent cleavage by NcoI and HinfI restriction endonucleases.

RESULTS—No difference was found between type 1 and type 2 diabetic patients in the prevalence of alleles of the Asp299Gly and Thr399Ile polymorphisms. In most cases, the alleles Gly299 and Ile399 occurred in a co-segregatory manner. The prevalence of the Gly299/Ile399 haplotype was 10.6 and 12.1% in type 1 and type 2 diabetic patients, respectively (P = 0.63). No association with diabetic nephropathy or diabetic neuropathy was found in type 1 diabetic patients. In type 2 diabetic patients, however, heterozygote carriers of the Asp299Gly and Thr399Ile genotypes had a significantly reduced prevalence of diabetic neuropathy (odds ratio 0.35 [95% CI 0.19–0.61]; P = 0.0002); no association with diabetic nephropathy was found.

CONCLUSIONS—Our data indicate that Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with reduced prevalence of diabetic neuropathy in type 2, but not in type 1, diabetes. Thus different mechanisms may be involved in the pathophysiology of diabetic neuropathy in type 1 and type 2 diabetes.

Abbreviations: AF, allelic frequency • CR, carrier rate • LPS, lipopolysaccharide • NF, nuclear factor • RAGE, receptor for advanced glycation end products • TLR, toll-like receptor


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Int ImmunolHome page
M. K. Mohammad, M. Morran, B. Slotterbeck, D. W. Leaman, Y. Sun, H. v. Grafenstein, S.-C. Hong, and M. F. McInerney
Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse
Int. Immunol., July 1, 2006; 18(7): 1101 - 1113.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
H. Yamasaki, H. Sasaki, K. Ogawa, T. Shono, S. Tamura, A. Doi, M. Sasahara, H. Kawashima, T. Nakao, H. Furuta, et al.
Uncoupling Protein 2 Promoter Polymorphism -866G/A Affects Peripheral Nerve Dysfunction in Japanese Type 2 Diabetic Patients
Diabetes Care, April 1, 2006; 29(4): 888 - 894.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Marsik, B. Jilma, C. Joukhadar, C. Mannhalter, O. Wagner, and G. Endler
The Toll-Like Receptor 4 Asp299Gly and Thr399Ile Polymorphisms Influence the Late Inflammatory Response in Human Endotoxemia
Clin. Chem., November 1, 2005; 51(11): 2178 - 2180.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.